[ad_1]
Dublin, March 07, 2022 (GLOBE NEWSWIRE) — The “Cell Based Assay & High Content Screening Markets. Market Forecasts by Application with Executive and Consultant Guides and including Customized Forecasting and Analysis.” report has been added to ResearchAndMarkets.com’s offering.
The report includes five year market forecasts.
Cell-Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as the race for a COVID-19 cure gains speed.
On top of this, new technology is allowing Cell-Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.
Key Topics Covered:
Market Guides
- Situation Analysis & COVID-19 Impact
- Guide for Executives and Marketing Staff
- Guide for Investment Analysts and Management Consultants
1. Introduction and Market Definition
1.1 What are Cell Based Assays?
1.2 Clinical Trial Failures
1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
1.2.2 Infectious Disease Will Play a Larger…
Full story available on Benzinga.com
[ad_2]
Source link
